EOS 3D Imaging: assessing the impact of brace treatment in adolescent idiopathic scoliosis

Abstract

One of the major revolutions in the field of adolescent idiopathic scoliosis (AIS) during the past 10 years is the development of 3D imaging devices in standing position, such as EOS (EOS Imaging). 3D vision of the spine is new; we need to be humble and learn how it may help in the management of AIS. But we now have access to the transverse plane deformity. We do not know how to heal idiopathic scoliosis. Thus, the main issue in the field of AIS management is to avoid progression of mild scoliosis. Brace treatment is the main treatment option for mild scoliotic patients during growth. However, the efficacy of brace treatment is not consensual. We have demonstrated through a 3D analysis of brace treatment that some braces are truly efficient, some are not and others worsen the spinal deformity. Therefore, we have to anticipate the effect of a brace on a specific patient. With 3D analysis we are now able to evaluate if a brace really improves the spinal shape in the 3 dimensions or not. Moreover, we have the patient 3D geometry (spine and rib cage) and we are able to collect objective clinical data that could help achieve relevant parametric finite element models. These models could help in the prediction of brace effect but they need to be validated with clinical data. We see a close future where we will all have the 3D trunk shape of our patients on our screens along with all computed angles we need and then an instant prediction for the best-fit brace geometry for our patient.

Keywords::

• 3D
• Brace treatment
• EOS Imaging
• finite element model
• idiopathic scoliosis

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.